Both in Pharmaceuticals
Minerva Neurosciences vs PDS Biotechnology
Over the past year NERV returned −39.3% and PDSB returned +54.2%; their daily moves had a correlation of 0.08.
NERV −39.3% PDSB +54.2%Growth of $1, one year, split-adjusted
| Metric | NERV | PDSB |
|---|---|---|
| Price | $2.32 | $1.44 |
| Market cap | $110.8M | $104.4M |
| Today | +3.57% | −7.10% |
| 1 month | −28.2% | +103.9% |
| 6 months | −61.8% | +46.8% |
| Year to date | −42.3% | +87.1% |
| 1 year | −45.2% | +42.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $75.3M | $1.2M |
| Dividend yield | — | — |
| Volatility (60d) | 80.2% | 315.7% |
| Short % of float | 6.0% | 8.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).